Judith James to Lupus Nephritis
This is a "connection" page, showing publications Judith James has written about Lupus Nephritis.
Connection Strength
3.884
-
Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial. Lancet Rheumatol. 2024 Mar; 6(3):e168-e177.
Score: 0.822
-
Genetics of Lupus Nephritis: Clinical Implications. Semin Nephrol. 2015 Sep; 35(5):396-409.
Score: 0.459
-
New perspectives and insights to Asian systemic lupus erythematosus: renal disease, genetic predisposition and disease activity. Int J Rheum Dis. 2013 Dec; 16(6):611-4.
Score: 0.407
-
A human-mouse atlas of intrarenal myeloid cells identifies conserved disease-associated macrophages in lupus nephritis. J Exp Med. 2025 Nov 03; 222(11).
Score: 0.230
-
Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis. J Clin Invest. 2025 Aug 15; 135(16).
Score: 0.226
-
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network. Arthritis Res Ther. 2024 02 20; 26(1):54.
Score: 0.206
-
Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis. JCI Insight. 2024 Jan 23; 9(2).
Score: 0.205
-
High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership. Rheumatology (Oxford). 2022 11 02; 61(11):4335-4343.
Score: 0.189
-
Urine Proteomics and Renal Single-Cell Transcriptomics Implicate Interleukin-16 in Lupus Nephritis. Arthritis Rheumatol. 2022 05; 74(5):829-839.
Score: 0.182
-
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE Network. Lupus Sci Med. 2021 08; 8(1).
Score: 0.173
-
Accelerating Medicines Partnership: Organizational Structure and Preliminary Data From the Phase 1 Studies of Lupus Nephritis. Arthritis Care Res (Hoboken). 2020 02; 72(2):233-242.
Score: 0.155
-
Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death. Clin Immunol. 2017 12; 185:3-9.
Score: 0.125
-
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol. 2014 Feb; 66(2):390-6.
Score: 0.103
-
ABIN1 dysfunction as a genetic basis for lupus nephritis. J Am Soc Nephrol. 2013 Nov; 24(11):1743-54.
Score: 0.100
-
Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes Immun. 2012 Apr; 13(3):232-8.
Score: 0.089
-
Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. Genes Immun. 2009 Jul; 10(5):470-7.
Score: 0.074
-
Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. Lupus. 2003; 12(2):99-106.
Score: 0.048
-
Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. Arthritis Rheum. 2012 Nov; 64(11):3687-94.
Score: 0.024
-
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis. 2011 Oct; 70(10):1752-7.
Score: 0.021
-
ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry. Ann Rheum Dis. 2010 Jul; 69(7):1329-32.
Score: 0.019
-
Evaluation of C1q genomic region in minority racial groups of lupus. Genes Immun. 2009 Jul; 10(5):517-24.
Score: 0.019
-
Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease. Arthritis Rheum. 1999 Jan; 42(1):69-75.
Score: 0.009